Literature DB >> 16137566

Glial activation spreads from specific cerebral foci and precedes neurodegeneration in presymptomatic ovine neuronal ceroid lipofuscinosis (CLN6).

Manfred J Oswald1, David N Palmer, Graham W Kay, Stephen J A Shemilt, Payam Rezaie, Jonathan D Cooper.   

Abstract

The neuronal ceroid lipofuscinoses (NCLs, Batten disease) are fatal inherited neurodegenerative diseases characterized by gross brain atrophy, blindness, and intracellular accumulation of lysosome-derived storage bodies. A CLN6 form in sheep is studied as a large animal model of the human diseases. This study describes neuropathological changes in brains from presymptomatic affected sheep. Activated astrocytes and focal clusters of activated microglia were present in outer layers of occipital and somatosensory cortical regions as early as 12 days of age, together with activated perivascular macrophages. Astrocytic activation and progressive transformation of microglia to brain macrophages preceded neurodegeneration and spread to different cortical areas, most prominently in regions associated with clinical symptoms. In contrast, storage body accumulation was much more evenly spread across regions. These data support suggestions that neurodegeneration and storage body accumulation may be independent manifestations of CLN6 mutation and indicate that glial cell activation may be an important mediator in pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16137566     DOI: 10.1016/j.nbd.2005.01.025

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  39 in total

1.  The development and characterisation of complex ovine neuron cultures from fresh and frozen foetal neurons.

Authors:  Graham W Kay; Manfred J Oswald; David N Palmer
Journal:  J Neurosci Methods       Date:  2006-02-17       Impact factor: 2.390

Review 2.  Mesenchymal stem cells as cellular vectors for pediatric neurological disorders.

Authors:  Donald G Phinney; Iryna A Isakova
Journal:  Brain Res       Date:  2014-05-22       Impact factor: 3.252

3.  Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease).

Authors:  Graham W Kay; Marcel M Verbeek; Julie M Furlong; Michèl A A P Willemsen; David N Palmer
Journal:  Neurochem Int       Date:  2009-08-05       Impact factor: 3.921

Review 4.  Astrocytes and lysosomal storage diseases.

Authors:  K V Rama Rao; T Kielian
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

Review 5.  Clarifying lysosomal storage diseases.

Authors:  Mark L Schultz; Luis Tecedor; Michael Chang; Beverly L Davidson
Journal:  Trends Neurosci       Date:  2011-06-30       Impact factor: 13.837

6.  An anti-neuroinflammatory that targets dysregulated glia enhances the efficacy of CNS-directed gene therapy in murine infantile neuronal ceroid lipofuscinosis.

Authors:  Shannon L Macauley; Andrew M S Wong; Charles Shyng; David P Augner; Joshua T Dearborn; Yewande Pearse; Marie S Roberts; Stephen C Fowler; Jonathan D Cooper; D Martin Watterson; Mark S Sands
Journal:  J Neurosci       Date:  2014-09-24       Impact factor: 6.167

7.  Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis.

Authors:  Catherine Kielar; Lucy Maddox; Ellen Bible; Charlie C Pontikis; Shannon L Macauley; Megan A Griffey; Michael Wong; Mark S Sands; Jonathan D Cooper
Journal:  Neurobiol Dis       Date:  2006-10-12       Impact factor: 5.996

8.  Protein product of CLN6 gene responsible for variant late-onset infantile neuronal ceroid lipofuscinosis interacts with CRMP-2.

Authors:  Jared W Benedict; Amanda L Getty; Thomas M Wishart; Thomas H Gillingwater; David A Pearce
Journal:  J Neurosci Res       Date:  2009-07       Impact factor: 4.164

9.  A new large animal model of CLN5 neuronal ceroid lipofuscinosis in Borderdale sheep is caused by a nucleotide substitution at a consensus splice site (c.571+1G>A) leading to excision of exon 3.

Authors:  Tony Frugier; Nadia L Mitchell; Imke Tammen; Peter J Houweling; Donald G Arthur; Graham W Kay; Otto P van Diggelen; Robert D Jolly; David N Palmer
Journal:  Neurobiol Dis       Date:  2007-09-29       Impact factor: 5.996

10.  Progressive thalamocortical neuron loss in Cln5 deficient mice: Distinct effects in Finnish variant late infantile NCL.

Authors:  Carina von Schantz; Catherine Kielar; Stine N Hansen; Charlie C Pontikis; Noreen A Alexander; Outi Kopra; Anu Jalanko; Jonathan D Cooper
Journal:  Neurobiol Dis       Date:  2009-05       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.